Cas:74467-01-9 (1Z)-N-hydroxy-2-methoxybenzenecarboximidoyl chloride manufacturer & supplier

Chemical Name:(1Z)-N-hydroxy-2-methoxybenzenecarboximidoyl chloride

CAS.NO:74467-01-9

Synonyms:2-methoxy-N-hydroxybenzenecarboxyimidoyl chloride;2-methoxybenzohydroximoyl chloride;2-methoxybenzohydroximinoyl chloride;(Z)-2-METHOXYBENZOYL CHLORIDE OXIME;2-methoxyphenyl hydroximoyl chloride;(1Z)-2-methoxy-N-oxidanyl-benzenecarboximidoyl chloride;N-hydroxy-2-methoxy-benzimidoyl chloride

Molecular Formula:C₈H₈ClNO₂

Molecular Weight:185.60800

HS Code:2925290090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:41.82000

Exact Mass:185.02400

LogP:2.06980

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 2-methoxy-N-hydroxybenzenecarboxyimidoyl chloride chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,N-hydroxy-2-methoxy-benzimidoyl chloride physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-methoxybenzohydroximinoyl chloride Use and application,2-methoxybenzohydroximinoyl chloride technical grade,usp/ep/jp grade.

Related News: A Phase 1/2 trial of the combination therapy has been fully enrolled, and the preliminary efficacy and safety data was presented at The American Society of Hematology (ASH) Annual Meeting in December 2018. (1Z)-N-hydroxy-2-methoxybenzenecarboximidoyl chloride manufacturer Fate Therapeutics is a clinical-stage biopharmaceutical company dedicated to the development of first-in-class cellular immunotherapies for cancer and immune disorders. (1Z)-N-hydroxy-2-methoxybenzenecarboximidoyl chloride supplier International Chemical Investors Group (ICIG) recently announced it has entered into a purchase agreement under which an affiliate of ICIG will acquire the pharmaceutical intermediates business from Genzyme Corporation. (1Z)-N-hydroxy-2-methoxybenzenecarboximidoyl chloride vendor Since the listing of high-barrier generic drugs involves quickly bypassing or challenging process patents of original research products within a short period of time, API companies play an important role in the process of marketing and sales of generic drugs. (1Z)-N-hydroxy-2-methoxybenzenecarboximidoyl chloride factory Fate Therapeutics is a clinical-stage biopharmaceutical company dedicated to the development of first-in-class cellular immunotherapies for cancer and immune disorders.